Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis

Paul W. Manley; Guido Bold; Josef Brüggen; G. Fendrich; Pascal Furet; Jürgen Mestan; Christian Schnell; Barbara Stolz; Thomas Meyer; Bernd Meyhack; Wilhelm Stark; André Strauss; Jeanette M. Wood

doi:10.1016/j.bbapap.2003.11.010

Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis

Paul W. Manley(Novartis Institutes for BioMedical Research), Guido Bold(Novartis Institutes for BioMedical Research), Josef Brüggen(Novartis (Switzerland)), G. Fendrich(Novartis Institutes for BioMedical Research), Pascal Furet(Novartis Institutes for BioMedical Research), Jürgen Mestan(Novartis Institutes for BioMedical Research), Christian Schnell(Novartis Institutes for BioMedical Research), Barbara Stolz(Novartis Institutes for BioMedical Research), Thomas Meyer(Novartis Institutes for BioMedical Research), Bernd Meyhack(Novartis Institutes for BioMedical Research), Wilhelm Stark(Novartis Institutes for BioMedical Research), André Strauss(Novartis Institutes for BioMedical Research), Jeanette M. Wood(Novartis Institutes for BioMedical Research)

Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics

December 9, 2003

10.1016/j.bbapap.2003.11.010

Cited by 134

Abstract

Related Papers

No related papers found

Powered by citation graph analysis